Under construction – not a live service
Sign in
Taking people in GermanyNo phase

Magnesium Blood Levels and Thinking Skills After Stroke

Studies whether blood magnesium levels relate to thinking skills in adults after stroke.

Plain-language title generated from the registry record
Registry title: Magnesium and Cognition After Stroke

Key facts

Where
Hessisch Oldendorf, GermanySee the site

Where in Germany

  • Institute for Neurorehabilitation Research, BDH-Clinic Hessich OldendorfHessisch Oldendorf, GermanyTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
BDH-Klinik Hessisch Oldendorf
Trial code
NCT05132517
Record updated
20 April 2026
Original description
Cognitive impairments such as memory impairments, word-finding difficulties, compromised orientation and perception are often observed in stroke patients.Read full original descriptionShow less

Relationship Between Magnesium Concentration in Blood and Kognitive Functions After Stroke

Cognitive impairments such as memory impairments, word-finding difficulties, compromised orientation and perception are often observed in stroke patients.

Low serum-mg-concentrations are associated with cognitive impairments in ischemic stroke patients one month after stroke onset. It is not clear, if cognitive impairments after stroke is caused by the mg-deficiency or by the stroke itself. Until now, no studies investigating the relationship between mg-concentration, stroke severity and cognition during treatment course are available. Thus, this study aimed to investigate the relationship between mg-concentration and cognition of stroke patients.

Inclusion: ischemic/hemmorhagic stroke; written consent form.

Exclusion: pre-existing mental disorder (depression) or present/prior long-term treatment (> 6 months) with psychotropic drugs; pre-existing dementia or cognitive impairment before stroke onset; pre-existing malign tumor disease; participation in another clinical trial within the past 30 days; pregnancy or breastfeeding.

ClinicalTrials.gov NCT05132517